Literature DB >> 9850324

A Le Fort I osteotomy approach to lateral sphenoid sinus encephalocoeles.

J M Reynolds1, A Tomkinson, R G Grigg, C F Perry.   

Abstract

Meningo-encephalocoeles of the skull base may present as spontaneous cerebrospinal fluid rhinorrhoea or acute meningitis. Previous approaches to midline skull base lesions have been either intracranial, via a craniotomy, or by transfacial or endoscopic extracranial approaches. This paper presents an alternative approach to lateral sphenoid sinus encephalocoeles through a Le Fort I osteotomy approach.

Entities:  

Mesh:

Year:  1998        PMID: 9850324     DOI: 10.1017/s0022215100141672

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  4 in total

1.  Endoscopic transorbital approach to anterolateral skull base through inferior orbital fissure: a cadaveric study.

Authors:  Bon-Jour Lin; Da-Tong Ju; Tzu-Hsien Hsu; Tzu-Tsao Chung; Wei-Hsiu Liu; Dueng-Yuan Hueng; Yuan-Hao Chen; Chung-Ching Hsia; Hsin-I Ma; Ming-Ying Liu; Hung-Chang Hung; Chi-Tun Tang
Journal:  Acta Neurochir (Wien)       Date:  2019-06-29       Impact factor: 2.216

2.  A modification of endoscopic endonasal approach for management of encephaloceles in sphenoid sinus lateral recess.

Authors:  M N El-Tarabishi; S A Fawaz; S M Sabri; M M El-Sharnobi; Ahmed Sweed
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-13       Impact factor: 2.503

3.  Temporal lobe encephalocele in the lateral recess of the sphenoid sinus presenting with intraventricular tension pneumocephalus.

Authors:  Toshika Ohkawa; Naoyuki Nakao; Yuji Uematsu; Toru Itakura
Journal:  Skull Base       Date:  2010-11

4.  Lateral sphenoid sinus recess cerebrospinal fluid leak: a case series.

Authors:  Nelson Almeida d'Ávila Melo; Bruno Barros Pinto Borges; Pedro Augusto Magliarelli Filho; Maria Dantas Costa Lima Godoy; Larissa Vilela Pereira; Fabio de Rezende Pinna; Richard Louis Voegels
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-20       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.